177,400 Shares in Colgate-Palmolive Company $CL Bought by WINTON GROUP Ltd

WINTON GROUP Ltd bought a new position in Colgate-Palmolive Company (NYSE:CL) during the fourth quarter, Holdings Channel reports. The fund bought 177,400 shares of the company’s stock, valued at approximately $14,018,000.

Other hedge funds have also modified their holdings of the company. Deseret Mutual Benefit Administrators grew its holdings in shares of Colgate-Palmolive by 5.8% during the fourth quarter. Deseret Mutual Benefit Administrators now owns 5,028 shares of the company’s stock valued at $397,000 after buying an additional 277 shares in the last quarter. Argent Advisors Inc. purchased a new position in shares of Colgate-Palmolive during the fourth quarter valued at $212,000. Vise Technologies Inc. grew its holdings in shares of Colgate-Palmolive by 67.9% during the fourth quarter. Vise Technologies Inc. now owns 44,670 shares of the company’s stock valued at $3,530,000 after buying an additional 18,065 shares in the last quarter. TD Asset Management Inc grew its holdings in shares of Colgate-Palmolive by 9.1% during the fourth quarter. TD Asset Management Inc now owns 3,176,651 shares of the company’s stock valued at $251,019,000 after buying an additional 265,643 shares in the last quarter. Finally, Intellectus Partners LLC grew its holdings in shares of Colgate-Palmolive by 79.7% during the fourth quarter. Intellectus Partners LLC now owns 13,886 shares of the company’s stock valued at $1,097,000 after buying an additional 6,158 shares in the last quarter. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $88.61 on Friday. The business’s 50-day moving average price is $86.49 and its two-hundred day moving average price is $85.93. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $99.33. The company has a market capitalization of $70.91 billion, a P/E ratio of 34.48, a price-to-earnings-growth ratio of 4.42 and a beta of 0.33.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating analysts’ consensus estimates of $0.94 by $0.03. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. During the same quarter in the previous year, the company posted $0.91 earnings per share. The business’s quarterly revenue was up 8.4% compared to the same quarter last year. Analysts anticipate that Colgate-Palmolive Company will post 3.82 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Monday, April 20th were paid a $0.53 dividend. This represents a $2.12 dividend on an annualized basis and a yield of 2.4%. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date was Monday, April 20th. Colgate-Palmolive’s dividend payout ratio is presently 82.49%.

Analyst Ratings Changes

CL has been the topic of a number of research analyst reports. Royal Bank Of Canada reiterated an “outperform” rating and set a $102.00 price target on shares of Colgate-Palmolive in a report on Monday, May 4th. Barclays lifted their price target on Colgate-Palmolive from $79.00 to $80.00 and gave the company an “equal weight” rating in a report on Tuesday, May 5th. UBS Group lifted their price target on Colgate-Palmolive from $98.00 to $100.00 and gave the company a “buy” rating in a report on Monday, May 4th. Weiss Ratings upgraded Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Finally, JPMorgan Chase & Co. lifted their price target on Colgate-Palmolive from $95.00 to $96.00 and gave the company an “overweight” rating in a report on Monday, May 4th. Twelve investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $95.88.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.